Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
17.48
+0.52 (3.07%)
Jan 22, 2025, 2:04 PM EST - Market open
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $5.63 billion as of January 22, 2025. Its market cap has increased by 176.40% in one year.
Market Cap
5.63B
Enterprise Value
5.57B
1-Year Change
176.40%
Ranking
Category
Stock Price
17.48
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $5.63B, an increase of 4,784.32%. That is a compound annual growth rate of 71.76%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 668.44B |
| UnitedHealth Group | 483.14B |
| Johnson & Johnson | 356.69B |
| Novo Nordisk | 355.54B |
| AbbVie | 305.03B |
| Merck & Co. | 243.45B |
| Thermo Fisher Scientific | 219.20B |
| Intuitive Surgical | 215.18B |